Last $8.66 USD
Change Today -0.10 / -1.14%
Volume 22.1K
CGIX On Other Exchanges
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Panna Sharma

Chief Executive Officer, President and Director, Cancer Genetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Panna L. Sharma, has been the Chief Executive Officer of Cancer Genetics, Inc. since May 2010 and serves as its President. Mr. Sharma founded TSG Partners (also known as The Sharma Group) in 2001 and served as its Chief Executive Officer and Managing Partner from 2001 to 2010. Prior to Sharma Group , Mr. Sharma spent three and one-half years at iXL Inc. (later merged with Scient) in the roles of Senior Vice President of E-Business Solutions and Chief Strategy Officer. ...

Read Full Background

Corporate Headquarters*

201 Route 17 North
Rutherford, New Jersey 07070

United States

Phone: 201-528-9200
Fax: 201-528-9201

Board Members Memberships*

Chief Executive Officer, President and Director


There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensation$649,040

Stock Options*

All Other Compensation$13,900
Exercisable Options126,586
Unexercisable Options225,414
Total Number of Options352,000

Total Compensation*

Total Annual Cash Compensation$662,940
Total Short Term Compensation$649,040
Other Long Term Compensation$13,900
Total Calculated Compensation$2,764,940
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CGIX:US $8.66 USD -0.10


Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
Samuel D. Riccitelli Chief Executive Officer, President and Director
Signal Genetics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANCER GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at